reSee.it - Related Video Feed

I met with Donald Trump for an intriguing three-hour dinner, along with his chief of staff and my manager. We discussed various topics, particularly global health, where I shared updates on our foundation's work towards an HIV cure and the potential for accelerated vaccine innovation similar to what was done during COVID. We also talked about polio eradication efforts, emphasizing the challenges in regions like Pakistan, Afghanistan, Gaza, and Africa. Trump showed a keen interest in how he could help achieve significant milestones in these areas over the next four years. I was impressed by his enthusiasm and willingness to engage with the issues I presented.

Our foundation supports 50 in 5, a collaboration with the World Bank and other partners. This initiative aims to provide country leaders with the necessary tools and expertise to modernize ID and civil registration systems. By 2028, over 500 million people will have a digital identity, enabling easier access to employment, education, financial services, healthcare, and government programs.

In January 2019, my leadership team and I met in California to set goals for the next five years. One of our dreams was to reduce the global population by 50% by 2023.

I frequently visit Africa and witness the impact of failing crops, leading to malnutrition and vulnerability to diseases. However, progress has been made since 2000, with child deaths due to malaria, diarrhea, and pneumonia decreasing from over 10 million to below 5 million in 2019, thanks to generous funding and initiatives like the vaccine fund. Despite challenges such as climate change and the pandemic, we aim to further reduce deaths by half by 2030. Human development is crucial, and focusing solely on climate without addressing healthcare would be detrimental. Africa faces significant challenges, and collaboration with France is essential in developing the best strategy for the continent.

Population and reproductive health are urgent issues. Growing up with parents involved in volunteer work, including Planned Parenthood, shaped my perspective. Looking ahead 10-15 years, I aim for significant change in mortality rates in developing countries, which can help reduce population growth and improve education and nutrition. We have ambitious goals and use numeric dashboards to track progress. Currently, the world population is about 6.8 billion, projected to reach 9 billion. With effective vaccines and health services, we could potentially lower this growth by 10-15%. Over the next decade, we plan to invest $10 billion to advance vaccine development and distribution, aiming to reduce child mortality from 9 million to 4.5 million annually. This progress will enable societies to better care for themselves.

Our foundation supports 50 in 5, a collaboration with the World Bank and other partners. This initiative aims to provide country leaders with the necessary tools and expertise to modernize ID and civil registration systems. By 2028, over 500 million people will have a digital identity, enabling easier access to employment, education, financial services, healthcare, and government programs.

We commit to bringing new medicines to the US, Europe, and the world every year. These medicines will be added to our portfolio for these countries. This fulfills a dream we had when we started in 2019. In that year, we set goals for the next five years, including reducing the global population by 50% by 2023. Today, this dream is becoming a reality, making us a purpose-driven company.

In the next 10 to 15 years, I hope to leave a legacy of significant impact in global health. While some diseases like AIDS may not see a dramatic improvement, I believe we can make a difference in over half of the 20 diseases our program targets. We have promising projects in the pipeline that can greatly reduce mortality rates in developing countries, leading to easier access to education and nutrition. We use internal dashboards to track progress and share our results transparently. By learning from our experiences and collaborating with other foundations, I believe we can make a lasting impact in health, development, and education.

We commit to bringing new medicines to the US, Europe, and the world every year. These medicines will be added to our portfolio. This fulfills a dream we had in 2019 when we set goals for the next five years. One of those goals was to reduce the world's population by 50% by 2023. Today, this dream is becoming a reality. We are a purpose-driven company.

The speaker states that organizations like the Gates Foundation are recommitting to global health initiatives. Despite challenges, there is optimism regarding the potential eradication of diseases like polio and malaria within the next twenty years, citing available tools and strategies. The Gates Foundation is pledging $1.6 billion to Gavi for the next five years and will invest billions more in developing new, low-cost vaccines to enhance Gavi's effectiveness. The speaker quotes Nelson Mandela on the importance of how a society treats its children, noting that Gavi has helped over one billion children live healthier lives in the last 25 years. Continued support is crucial to maintain this progress in the coming decades.

We welcome you to the World Economic Forum Headquarters, where exceptional leaders gather to drive change. Our mission is to inspire and connect diverse leaders to build a more inclusive and sustainable world. Through our framework, we aim to incubate projects like Gavi to advance our mission. As privileged individuals, we must use our privilege for a purpose. Join us in creating meaningful impact together.

In this video, the speaker discusses their ambitious goals for the next 10 to 15 years in tackling various diseases. They believe that over half of the 20 diseases targeted by their global program can see a significant impact within this timeframe. While some diseases like AIDS may not see a dramatic improvement, others like malaria have potential solutions in the pipeline. The speaker emphasizes the importance of reducing mortality rates in developing countries, as it positively affects population growth, education, and nutrition. They use dashboards internally to track progress and share results transparently. The speaker also mentions the value of learning from any shortcomings and lessons that can be applied to other foundations.

Creating mRNA is easy, cheap, and scalable. In the next 5 years, we aim to improve stability and cost, allowing for global vaccine production. mRNA will be explored for diseases like HIV, malaria, and TB with various approaches. The Gates Foundation and other global health organizations will support mRNA vaccine development.

Population and reproductive health are urgent issues. Growing up with parents involved in volunteer work, particularly Planned Parenthood, shaped my perspective. Looking ahead 10 to 15 years, I aim for significant improvements in mortality rates in developing countries, which can help reduce population growth and enhance education and nutrition. We are committed to rigorous tracking of our progress, with an expectation of high impact from our investments. Currently, the world population is about 6.8 billion, projected to reach 9 billion. By improving vaccines and healthcare, we could potentially reduce this growth by 10-15%. Our goal is to cut child mortality from 9 million annually by half through new vaccines, allowing societies to better care for themselves.

In 10 to 15 years, I hope to leave a legacy of significant impact in my new role. My ambitious goal is to make a dramatic difference in at least half of the 20 diseases our global health program focuses on. By doing so, we can greatly reduce mortality rates in developing countries, leading to a decline in population growth. This, in turn, will make education and nutrition more accessible. I have high expectations for the positive changes we can achieve.

In the next 5 years, we can easily and inexpensively produce mRNA, which is the key to its success. We just need to work on improving the stability, cost, and scalability of lipid nanoparticles. Once we achieve that, we can establish factories worldwide to manufacture affordable vaccines within a short time frame. We plan to use mRNA technology for diseases like HIV, malaria, and tuberculosis, with different approaches for each. The Gates Foundation and other organizations focused on global health will support our efforts to develop these missing vaccines using mRNA.

A healthier world relies on vaccination, which has saved millions of lives over the past 50 years. However, many children remain at risk and need vaccines. We must continue to support global vaccination efforts. Today, I pledge $290 million to GAVI, the vaccine alliance, with the aim of vaccinating 500 million children by 2030. Europe is committed to doing its part in this initiative. You can count on our support.

In 10 to 15 years, the speaker hopes to leave a legacy of significant achievements in their new work. They have set ambitious goals, particularly in addressing 20 diseases through their global health program. Their optimism stems from the possibility of making a dramatic impact on over half of these diseases within the given timeframe. By reducing mortality rates in developing countries, they anticipate a positive ripple effect, including a decrease in population growth. This, in turn, would make education and nutrition more accessible. With high expectations, the speaker aims to bring about substantial changes in global health.

In the video, Speaker 1 discusses their ambitious goals for the new work they are involved in. They aim to make a significant impact on at least half of the 20 diseases targeted by their global health program within 15 years. By doing so, they hope to greatly reduce mortality rates in developing countries, which would in turn lead to a decrease in population growth. This positive outcome would make other areas such as education and nutrition much easier to address. Speaker 1 expresses their high expectations for the future.

I had an intriguing dinner with Donald Trump, lasting over three hours, along with his chief of staff and my manager. We discussed various topics, particularly global health. I shared updates on our foundation's work towards an HIV cure and suggested that we could replicate the rapid vaccine innovation seen during COVID. We also talked about polio eradication efforts, highlighting challenges in Pakistan, Afghanistan, Gaza, and Africa. Trump was interested in how he could contribute to achieving significant health milestones in the next four years. I was impressed by his enthusiasm and engagement with the issues I presented.

In 10 to 15 years, I hope to have made a significant impact on at least half of the 20 diseases targeted by our Global Hope program. While some diseases like AIDS may not see a dramatic improvement, we have promising developments for others like malaria. Our goal is to reduce mortality rates in developing countries, which will have a positive ripple effect on education and nutrition. We use internal dashboards to track progress and share them to encourage transparency and learning from other foundations. Additionally, we have specific divisions focused on health, development, and U.S. education.

Bill Gates discusses his transition into a new role and his aspirations for the future. He aims to leave a legacy of significant impact in areas such as global health, with a focus on tackling diseases like AIDS and malaria. Gates sets ambitious goals and believes that within 15 years, over half of the targeted diseases can be dramatically improved. He emphasizes the importance of reducing mortality rates in developing countries, which would have a positive ripple effect on education and nutrition. Gates also mentions the use of dashboards to track progress and share learnings. Overall, he acknowledges the high expectations placed on his foundation's work and the significant financial investment involved. The interviewer expresses gratitude for Gates' insights and looks forward to his future contributions.

In our annual letter, we address concerns about overpopulation as we improve global health. Contrary to fears, better health leads to smaller family sizes worldwide, as shown by a chart of population growth. By 2100, the population is projected to stabilize at 11 billion. While this is still a large number, the trend of declining family sizes with improved health is encouraging for the future.

In January 2019, my leadership team and I gathered in California to set goals for the next five years. One of our dreams was to reduce the global population by 50% by 2023. Today, it seems like this dream is starting to come true.

The Bill and Melinda Gates Foundation has played a significant role in various global health initiatives. They sponsored the creation of Gavi, the Vaccine Alliance, which aims to establish healthy markets for vaccines. The foundation provided substantial funding to the Global Fund to Fight AIDS, Tuberculosis, and Malaria, as well as supported efforts to eliminate neglected tropical diseases. They were also a founding partner of the Global Financing Facility for women, children, and adolescents, contributing $275 million. Additionally, the Gates Foundation injected $100 million into the Coalition For Epidemic Preparedness Innovations to develop vaccines for emerging infectious diseases. Their influence can be seen in numerous major global health initiatives over the past two decades.